Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Randomized, International, Multicenter, Open Label, With Blinded Adjudication of Outcomes, Non-Inferiority Clinical Trial to Explore the Safety and Efficacy of Ticagrelor Compared With Clopidogrel in Patients With Acute Coronary Syndrome With ST Elevation Treated With Pharmacological Thrombolysis.

NCT02298088 is registered in ClinicalTrials.gov with Hospital do Coracao as lead sponsor.

NCT NCT02298088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02298088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Randomized, International, Multicenter, Open Label, With Blinded Adjudication of Outcomes, Non-Inferiority Clinical Trial to Explore the Safety and Efficacy of Ticagrelor Compared With Clopidogrel in Patients With Acute Coronary Syndrome With ST Elevation Treated With Pharmacological Thrombolysis.
Lead sponsor
Hospital do Coracao
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2015
Completion date
January 31, 2019
Enrollment
3,799 (actual)
Sites
153

Conditions

As the registry lists them; a condition with its own page is linked.

acute st segment elevation myocardial infarction, thrombolysis in myocardial infarction flow